Bouvel Investment Partners LLC Lowers Stock Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Bouvel Investment Partners LLC cut its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 3.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 90,992 shares of the construction company’s stock after selling 2,768 shares during the quarter. Bouvel Investment Partners LLC owned about 0.12% of Aspen Aerogels worth $2,520,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of ASPN. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Aspen Aerogels by 10.3% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,310 shares of the construction company’s stock worth $341,000 after acquiring an additional 1,339 shares in the last quarter. nVerses Capital LLC lifted its stake in shares of Aspen Aerogels by 45.0% in the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock worth $161,000 after acquiring an additional 1,800 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in Aspen Aerogels by 15.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 14,580 shares of the construction company’s stock worth $257,000 after buying an additional 1,938 shares in the last quarter. Point72 Hong Kong Ltd purchased a new stake in Aspen Aerogels in the 2nd quarter worth about $84,000. Finally, Quent Capital LLC acquired a new position in shares of Aspen Aerogels during the 3rd quarter valued at about $118,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Roth Mkm lowered their target price on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research report on Friday, November 8th. Barclays dropped their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Tuesday. TD Cowen increased their target price on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a report on Wednesday. Finally, HC Wainwright reaffirmed a “buy” rating and set a $30.00 target price on shares of Aspen Aerogels in a research report on Wednesday, October 16th. One equities research analyst has rated the stock with a sell rating, nine have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Aspen Aerogels currently has an average rating of “Moderate Buy” and an average price target of $28.70.

Aspen Aerogels Stock Down 1.6 %

Shares of ASPN stock opened at $15.54 on Thursday. The company’s fifty day moving average price is $22.66 and its 200-day moving average price is $24.74. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.82. Aspen Aerogels, Inc. has a one year low of $9.57 and a one year high of $33.15. The company has a market capitalization of $1.28 billion, a price-to-earnings ratio of 1,555.56 and a beta of 2.21.

Insider Buying and Selling at Aspen Aerogels

In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the sale, the chief financial officer now directly owns 20,790 shares in the company, valued at $626,610.60. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now owns 20,790 shares in the company, valued at approximately $626,610.60. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Donald R. Young sold 63,355 shares of the stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by company insiders.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.